Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
Insider tradingForm 4

Krystal Biotech, Inc. (KRYS) Insider Trading

3 open-market trades reported since Aug 14, 2026: 0 purchases worth $0 and 3 sales worth $26.2M.

By insider

InsiderRoleBuysBoughtSellsSoldLatest
Krish S. KrishnanCEO0$01$8.98MSep 4, 2026
Suma KrishnanPresident0$01$8.98MSep 4, 2026
Dino A. RossiDirector0$01$8.23MAug 14, 2026
ADVERTISEMENT
728 × 90 ad slot320 × 100 ad slot

All trades

KRYS insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHolding3 mo. afterFiling
Sep 4Sep 4Krish S. KrishnanCEOCEO▼ SELL10b5-125,000359.32$8.98M−1.8%Form 4 ↗
Sep 4Sep 4Suma KrishnanPresidentPresident▼ SELL10b5-125,000359.32$8.98M−1.9%Form 4 ↗
Aug 14Aug 14Dino A. RossiDirectorDirector▼ SELL25,000329.12$8.23M−33%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings